(Hypertension. 1998;31:57.)
© 1998 American Heart Association, Inc.
Scientific Contributions |
Target-Organ Damage in Stage I Hypertensive Subjects With White Coat and Sustained Hypertension
Results From the HARVEST Study
From the Clinica Medica 1, University of Padova, Italy.
Correspondence to Prof Paolo Palatini, MD, Trial Coordinator, Clinica Medica 1, University of Padova, 35126 Padova, Italy.
Abstract—Controversy remains on whether white coat hypertension is a benign clinical condition or carries an increased risk of target-organ damage. Nine hundred forty-two stage I hypertensive subjects enrolled in the HARVEST trial underwent 24-hour ambulatory blood pressure monitoring and urine collection for albumin measurement. Reliable echocardiographic data were obtained in 722 subjects. White coat hypertensive subjects were defined on the basis of three different partition values: mean daytime blood pressure <130/90 mm Hg, <135/85 mm Hg, or <140/90 mm Hg. Ninety-five normotensive subjects with similar age and sex distribution were studied as controls. With all threshold levels, left ventricular mass index and wall thicknesses were greater in the sustained hypertensive subjects than in the white coat hypertensive subjects, also when these differences were adjusted for blood pressure readings taken in the office. Relative wall thickness was similar in the two hypertensive groups. All echocardiographic dimensional data were greater in the white coat hypertensive subjects than in the normotensive subjects. Urinary albumin and the prevalence of microalbuminuria were also greater in the sustained hypertensive subjects than in the white coat hypertensive subjects. No significant differences in urinary albumin were found between the white coat hypertensive and the normotensive subjects. These results show that within a population of subjects with stage I hypertension, subjects with white coat hypertension have a smaller degree of hypertensive complications than those with sustained hypertension, irrespective of their blood pressure levels taken in the office. However, in comparison with normotensive subjects, white coat hypertensive subjects seem to be at greater risk. Cardiac involvement seems to precede glomerular damage in the early stage of hypertension.
Key Words: ambulatory monitoring • hypertension, white coat • hypertrophy, left ventricular • microalbuminuria • echocardiography
This article has been cited by other articles:
 |
|
 |
|
  E. Urbina, B. Alpert, J. Flynn, L. Hayman, G. A. Harshfield, M. Jacobson, L. Mahoney, B. McCrindle, M. Mietus-Snyder, J. Steinberger, et al. Ambulatory Blood Pressure Monitoring in Children and Adolescents: Recommendations for Standard Assessment: A Scientific Statement From the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee of the Council on Cardiovascular Disease in the Young and the Council for High Blood Pressure Research Hypertension, September 1, 2008; 52(3): 433 - 451. [Full Text] [PDF]
|
|
|
|
 |
|
 E. S. Ommen, B. Schroppel, J.-Y. Kim, G. Gaspard, E. Akalin, G. de Boccardo, V. Sehgal, M. Lipkowitz, and B. Murphy Routine Use of Ambulatory Blood Pressure Monitoring in Potential Living Kidney Donors Clin. J. Am. Soc. Nephrol., September 1, 2007; 2(5): 1030 - 1036. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Kato, T. Horio, M. Tomiyama, K. Kamide, S. Nakamura, F. Yoshihara, H. Nakata, H. Nakahama, and Y. Kawano Reverse white-coat effect as an independent risk for microalbuminuria in treated hypertensive patients Nephrol. Dial. Transplant., March 1, 2007; 22(3): 911 - 916. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D Erdogan, H Gullu, M Caliskan, I Yildirim, D Tok, and H Muderrisoglu Coronary flow reserve is preserved in white-coat hypertension Heart, August 1, 2006; 92(8): 1109 - 1112. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Verdecchia, G. P. Reboldi, F. Angeli, G. Schillaci, J. E. Schwartz, T. G. Pickering, Y. Imai, T. Ohkubo, and K. Kario Short- and Long-Term Incidence of Stroke in White-Coat Hypertension Hypertension, February 1, 2005; 45(2): 203 - 208. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Garcia-Rio, J. M. Pino, A. Alonso, M. A. Arias, I. Martinez, D. Alvaro, and J. Villamor White Coat Hypertension in Patients With Obstructive Sleep Apnea-Hypopnea Syndrome Chest, March 1, 2004; 125(3): 817 - 822. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. A. Smith, L. N. Graham, A. F. Mackintosh, J. B. Stoker, and D. A. S. G. Mary Sympathetic neural mechanisms in white-coat hypertension J. Am. Coll. Cardiol., July 3, 2002; 40(1): 126 - 132. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Bjorklund, L. Lind, B. Vessby, B. Andren, and H. Lithell Different Metabolic Predictors of White-Coat and Sustained Hypertension Over a 20-Year Follow-Up Period: A Population-Based Study of Elderly Men Circulation, July 2, 2002; 106(1): 63 - 68. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Moser White-Coat Hypertension--To Treat or Not to Treat: A Clinical Dilemma Arch Intern Med, December 10, 2001; 161(22): 2655 - 2656. [Full Text] [PDF]
|
|
|
|
|
|
A. M. Grandi, R. Broggi, S. Colombo, R. Santillo, D. Imperiale, A. Bertolini, L. Guasti, and A. Venco Left Ventricular Changes in Isolated Office Hypertension: A Blood Pressure-Matched Comparison With Normotension and Sustained Hypertension Arch Intern Med, December 10, 2001; 161(22): 2677 - 2681. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Pedrinelli, G. Dell'Omo, G. Penno, and M. Mariani Non-diabetic microalbuminuria, endothelial dysfunction and cardiovascular disease Vascular Medicine, November 1, 2001; 6(4): 257 - 264. [Abstract] [PDF]
|
|
|
|
|
|
G. Bobrie, N. Genes, L. Vaur, P. Clerson, B. Vaisse, J.-M. Mallion, and G. Chatellier Is "Isolated Home" Hypertension as Opposed to "Isolated Office" Hypertension a Sign of Greater Cardiovascular Risk? Arch Intern Med, October 8, 2001; 161(18): 2205 - 2211. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Kario, K. Shimada, J. E. Schwartz, T. Matsuo, S. Hoshide, and T. G. Pickering Silent and clinically overt stroke in older Japanese subjects with white-coat and sustained hypertension J. Am. Coll. Cardiol., July 1, 2001; 38(1): 238 - 245. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Zeltner, C. Delles, M. Schneider, W. Siffert, and R. E. Schmieder G-Protein {beta}3 Subunit Gene (GNB3) 825T Allele Is Associated With Enhanced Renal Perfusion in Early Hypertension Hypertension, March 1, 2001; 37(3): 882 - 886. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. H. Fagard, J. A. Staessen, L. Thijs, J. Gasowski, C. J. Bulpitt, D. Clement, P. W. de Leeuw, J. Dobovisek, M. Jaaskivi, G. Leonetti, et al. Response to Antihypertensive Therapy in Older Patients With Sustained and Nonsustained Systolic Hypertension Circulation, September 5, 2000; 102(10): 1139 - 1144. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. F. Muldoon, P. Nazzaro, K. Sutton-Tyrrell, and S. B. Manuck White-Coat Hypertension and Carotid Artery Atherosclerosis: A Matching Study Arch Intern Med, May 22, 2000; 160(10): 1507 - 1512. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C D A Goonasekera and M J Dillon Current topic: Measurement and interpretation of blood pressure Arch. Dis. Child., March 1, 2000; 82(3): 261 - 265. [Full Text]
|
|
|
|
|
|
J. A. Staessen, E. T. O’Brien, E. Sandoya, F. Nieto, C. Schettini, M. Bianchi, and H. Senra Ambulatory Blood Pressure: Normality and Comparison With Other Measurements Hypertension, March 1, 2000; e8(3): . [Full Text]
|
|
|
|
|
|
P. Palatini, E. Casiglia, S. Julius, and A. C. Pessina High Heart Rate: A Risk Factor for Cardiovascular Death in Elderly Men Arch Intern Med, March 22, 1999; 159(6): 585 - 592. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Bursztyn, P. Palatini, and P. Mormino Effect of Daytime Sleep on Blood Pressure Monitoring in HARVEST Study Results • Response Hypertension, August 1, 1998; 32(2): 377 - 378. [Full Text]
|
|
|
|
 |
|
 Just How Serious Is White-Coat Hypertension? Journal Watch Cardiology, February 27, 1998; 1998(227): 7 - 7. [Full Text]
|
|